Globus Medical completes acquisition of Nevro
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 03 2025
0mins
Should l Buy GMED?
Acquisition Announcement: Globus Medical has completed its acquisition of Nevro, enhancing its presence in the musculoskeletal market and tapping into a $2.5 billion opportunity.
Future Plans: The company intends to discuss the benefits of this acquisition and its expanded product offerings during its first quarter earnings conference in May.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GMED?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GMED
Wall Street analysts forecast GMED stock price to rise
13 Analyst Rating
9 Buy
4 Hold
0 Sell
Moderate Buy
Current: 87.740
Low
87.00
Averages
101.00
High
114.00
Current: 87.740
Low
87.00
Averages
101.00
High
114.00
About GMED
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery techniques. It includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
2026 Economic Outlook and Uber Developments
- GDP Growth Slowdown: The GDP growth rate for Q1 2026 is only 0.7%, significantly lower than the previous estimate of 1.4%, indicating a sluggish economic recovery that may dampen investor confidence and negatively impact stock market performance.
- Rising Inflation Pressure: With inflation exceeding 3% in January, combined with slowing GDP growth, concerns about stagflation may arise, leading to reduced consumer spending and threatening corporate profitability.
- Surge in Oil Prices: West Texas Intermediate crude oil prices have surged from $57 on January 2 to $93, even exceeding $100 at times, increasing consumer energy expenditure pressure and potentially suppressing spending in other areas.
- Uber's Autonomous Driving Partnerships: Uber has recently formed partnerships with several companies, including Waymo and Lucid, indicating its proactive positioning in the autonomous driving sector, which may lay the groundwork for future market share growth.
See More
2026 Economic Outlook and Oil Price Fluctuations
- GDP Growth Slowdown: The GDP growth rate for Q1 2026 is only 0.7%, significantly lower than the previous estimate of 1.4%, indicating economic stagnation that may heighten investor concerns about future economic prospects.
- High Inflation Pressure: With inflation exceeding 3% in January, combined with low growth, market fears of stagflation are rising, which could negatively impact consumer spending and business investment decisions, further dragging down economic recovery.
- Surging Oil Prices Impact: As of the recording date, West Texas Intermediate crude oil prices have reached $93 per barrel, a significant increase from $57 on January 2, which may force consumers to cut back on other expenditures due to rising energy costs, affecting overall economic activity.
- Geopolitical Risks: The rise in oil prices is primarily driven by geopolitical conflicts rather than demand growth, particularly due to uncertainties surrounding Iran, which could lead to a more pessimistic economic outlook, necessitating close monitoring of related developments.
See More
Omnicell Advances Vision of Autonomous Pharmacy Amid Challenges
- Vision for Autonomous Pharmacy: Omnicell is committed to advancing the industry-defined vision of the autonomous pharmacy, aiming for zero-error medication management by enhancing operational efficiencies, having expanded from a single-point solution to a diversified product platform over recent years, thereby strengthening its market competitiveness.
- Expansion of SaaS and Expert Services: The company is steadily increasing revenue from its SaaS and Expert Services through acquisitions and new platform launches, with several health systems committing to its inventory optimization service in Q4 2025, indicating robust market demand.
- Strong Financial Health: As of Q4 2025, Omnicell reported cash and cash equivalents of $197 million against total debt of $168 million, reflecting a solid solvency position with a debt-to-capital ratio reduced to 12.1%, which supports future investments and expansion.
- Cost Pressures Impacting Margins: Despite successes in various sectors, Omnicell faced challenges from labor shortages and rising raw material costs, leading to a year-over-year decline of approximately 4 percentage points in non-GAAP gross margin in Q4 2025, which may strain profit margins.
See More
Intuitive Surgical Acquires European Distribution Business
- Acquisition of European Business: Intuitive Surgical has completed the acquisition of distribution businesses from ab medica, Abex, and Excelencia Robótica, enabling direct operations in Italy, Spain, and Portugal, which is expected to enhance the company's competitiveness in the European market.
- Market Integration and Leadership: Following the acquisition, operations have been integrated into ISRG's European commercial organization, led by Senior Vice President Dirk Barten, aimed at improving customer responsiveness and market adaptability.
- Surgical System Growth: By the end of 2025, ISRG's installed base of da Vinci surgical systems in Italy, Spain, and Portugal will exceed 470 units, with the Ion platform recently launched in Italy and Spain, indicating ongoing growth potential in the European market.
- Optimistic Market Outlook: The European surgical robots market is projected to grow from $2.10 billion in 2024 to $5.21 billion by 2031, with a CAGR of 14%, and ISRG is well-positioned to benefit from this growth due to its strong market presence.
See More
Executive Change: Kelly Huller Appointed
- Executive Appointment: Kelly Huller has been appointed as Executive Vice President, General Counsel, and Corporate Secretary as of February 25, 2026, indicating a strengthening of the company's leadership in legal and compliance matters aimed at enhancing corporate governance.
- Strategic Implications: Huller’s appointment reflects the company's commitment to legal compliance and risk management, which is expected to facilitate more effective operations in a complex legal environment, thereby boosting investor confidence.
- Industry Context: Given the increasingly stringent regulatory landscape, Huller’s extensive experience will provide essential legal support to help the company navigate potential legal challenges and ensure compliance.
- Future Outlook: Huller’s addition is viewed as part of the company’s strategic transformation, aimed at supporting long-term growth objectives and market competitiveness through a strengthened legal team.
See More
Dow Futures Decline as Nvidia Shares Retreat Despite Strong Earnings
- Nvidia Earnings Reaction: Nvidia reported strong earnings and guidance, yet its shares fell in after-hours trading, indicating market concerns over high valuations that could undermine investor confidence.
- Market Trend Shift: The S&P 500 has regained its position above the 50-day moving average, suggesting a short-term improvement in market sentiment; however, overall market uncertainty remains, necessitating cautious investor strategies.
- Dow Futures Movement: Dow futures are declining, reflecting investor caution towards tech stocks, particularly following a pullback in shares of leading companies like Nvidia, which may trigger broader market volatility.
- Investor Strategy Adjustment: As market sentiment shifts, investors may need to reassess their portfolios, especially in light of the unstable performance of tech stocks, seeking more stable investment opportunities.
See More
2026 Economic Outlook and Uber Developments
- GDP Growth Slowdown: The GDP growth rate for Q1 2026 is only 0.7%, significantly lower than the previous estimate of 1.4%, indicating a sluggish economic recovery that may dampen investor confidence and negatively impact stock market performance.
- Rising Inflation Pressure: With inflation exceeding 3% in January, combined with slowing GDP growth, concerns about stagflation may arise, leading to reduced consumer spending and threatening corporate profitability.
- Surge in Oil Prices: West Texas Intermediate crude oil prices have surged from $57 on January 2 to $93, even exceeding $100 at times, increasing consumer energy expenditure pressure and potentially suppressing spending in other areas.
- Uber's Autonomous Driving Partnerships: Uber has recently formed partnerships with several companies, including Waymo and Lucid, indicating its proactive positioning in the autonomous driving sector, which may lay the groundwork for future market share growth.
See More
2026 Economic Outlook and Oil Price Fluctuations
- GDP Growth Slowdown: The GDP growth rate for Q1 2026 is only 0.7%, significantly lower than the previous estimate of 1.4%, indicating economic stagnation that may heighten investor concerns about future economic prospects.
- High Inflation Pressure: With inflation exceeding 3% in January, combined with low growth, market fears of stagflation are rising, which could negatively impact consumer spending and business investment decisions, further dragging down economic recovery.
- Surging Oil Prices Impact: As of the recording date, West Texas Intermediate crude oil prices have reached $93 per barrel, a significant increase from $57 on January 2, which may force consumers to cut back on other expenditures due to rising energy costs, affecting overall economic activity.
- Geopolitical Risks: The rise in oil prices is primarily driven by geopolitical conflicts rather than demand growth, particularly due to uncertainties surrounding Iran, which could lead to a more pessimistic economic outlook, necessitating close monitoring of related developments.
See More
Omnicell Advances Vision of Autonomous Pharmacy Amid Challenges
- Vision for Autonomous Pharmacy: Omnicell is committed to advancing the industry-defined vision of the autonomous pharmacy, aiming for zero-error medication management by enhancing operational efficiencies, having expanded from a single-point solution to a diversified product platform over recent years, thereby strengthening its market competitiveness.
- Expansion of SaaS and Expert Services: The company is steadily increasing revenue from its SaaS and Expert Services through acquisitions and new platform launches, with several health systems committing to its inventory optimization service in Q4 2025, indicating robust market demand.
- Strong Financial Health: As of Q4 2025, Omnicell reported cash and cash equivalents of $197 million against total debt of $168 million, reflecting a solid solvency position with a debt-to-capital ratio reduced to 12.1%, which supports future investments and expansion.
- Cost Pressures Impacting Margins: Despite successes in various sectors, Omnicell faced challenges from labor shortages and rising raw material costs, leading to a year-over-year decline of approximately 4 percentage points in non-GAAP gross margin in Q4 2025, which may strain profit margins.
See More
Intuitive Surgical Acquires European Distribution Business
- Acquisition of European Business: Intuitive Surgical has completed the acquisition of distribution businesses from ab medica, Abex, and Excelencia Robótica, enabling direct operations in Italy, Spain, and Portugal, which is expected to enhance the company's competitiveness in the European market.
- Market Integration and Leadership: Following the acquisition, operations have been integrated into ISRG's European commercial organization, led by Senior Vice President Dirk Barten, aimed at improving customer responsiveness and market adaptability.
- Surgical System Growth: By the end of 2025, ISRG's installed base of da Vinci surgical systems in Italy, Spain, and Portugal will exceed 470 units, with the Ion platform recently launched in Italy and Spain, indicating ongoing growth potential in the European market.
- Optimistic Market Outlook: The European surgical robots market is projected to grow from $2.10 billion in 2024 to $5.21 billion by 2031, with a CAGR of 14%, and ISRG is well-positioned to benefit from this growth due to its strong market presence.
See More
Executive Change: Kelly Huller Appointed
- Executive Appointment: Kelly Huller has been appointed as Executive Vice President, General Counsel, and Corporate Secretary as of February 25, 2026, indicating a strengthening of the company's leadership in legal and compliance matters aimed at enhancing corporate governance.
- Strategic Implications: Huller’s appointment reflects the company's commitment to legal compliance and risk management, which is expected to facilitate more effective operations in a complex legal environment, thereby boosting investor confidence.
- Industry Context: Given the increasingly stringent regulatory landscape, Huller’s extensive experience will provide essential legal support to help the company navigate potential legal challenges and ensure compliance.
- Future Outlook: Huller’s addition is viewed as part of the company’s strategic transformation, aimed at supporting long-term growth objectives and market competitiveness through a strengthened legal team.
See More
Dow Futures Decline as Nvidia Shares Retreat Despite Strong Earnings
- Nvidia Earnings Reaction: Nvidia reported strong earnings and guidance, yet its shares fell in after-hours trading, indicating market concerns over high valuations that could undermine investor confidence.
- Market Trend Shift: The S&P 500 has regained its position above the 50-day moving average, suggesting a short-term improvement in market sentiment; however, overall market uncertainty remains, necessitating cautious investor strategies.
- Dow Futures Movement: Dow futures are declining, reflecting investor caution towards tech stocks, particularly following a pullback in shares of leading companies like Nvidia, which may trigger broader market volatility.
- Investor Strategy Adjustment: As market sentiment shifts, investors may need to reassess their portfolios, especially in light of the unstable performance of tech stocks, seeking more stable investment opportunities.
See More
